These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


253 related items for PubMed ID: 3928750

  • 1. Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.
    Nedwin GE, Svedersky LP, Bringman TS, Palladino MA, Goeddel DV.
    J Immunol; 1985 Oct; 135(4):2492-7. PubMed ID: 3928750
    [Abstract] [Full Text] [Related]

  • 2. Interferon-gamma enhances induction of lymphotoxin in recombinant interleukin 2-stimulated peripheral blood mononuclear cells.
    Svedersky LP, Nedwin GE, Goeddel DV, Palladino MA.
    J Immunol; 1985 Mar; 134(3):1604-8. PubMed ID: 3918106
    [Abstract] [Full Text] [Related]

  • 3. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
    Gomez MJ, Torosantucci A, Quinti I, Testa U, Peschle C, Cassone A.
    Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
    [Abstract] [Full Text] [Related]

  • 4. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM, Ortaldo JR, Shalaby MR, Svedersky LP, Nedwin GE, Bringman TS, Hass PE, Aggarwal BB, Herberman RB, Goeddel DV.
    J Immunol; 1986 Oct 15; 137(8):2592-8. PubMed ID: 3760569
    [Abstract] [Full Text] [Related]

  • 5. Initial characterization of a lymphokine pathway for the immunologic induction of tumor necrosis factor-alpha release from human peripheral blood mononuclear cells.
    Kornbluth RS, Gregory SA, Edgington TS.
    J Immunol; 1988 Sep 15; 141(6):2006-15. PubMed ID: 3139748
    [Abstract] [Full Text] [Related]

  • 6. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro.
    Ghoneum M, Jewett A.
    Cancer Detect Prev; 2000 Sep 15; 24(4):314-24. PubMed ID: 11059563
    [Abstract] [Full Text] [Related]

  • 7. Production and regulation of interleukin 6 in human B lymphoid cells.
    Hutchins D, Cohen BB, Steel CM.
    Eur J Immunol; 1990 May 15; 20(5):961-8. PubMed ID: 2113479
    [Abstract] [Full Text] [Related]

  • 8. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses.
    Scheurich P, Thoma B, Ucer U, Pfizenmaier K.
    J Immunol; 1987 Mar 15; 138(6):1786-90. PubMed ID: 3029221
    [Abstract] [Full Text] [Related]

  • 9. Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production.
    Konur A, Schulz U, Eissner G, Andreesen R, Holler E.
    Br J Dermatol; 2005 Jun 15; 152(6):1134-42. PubMed ID: 15948973
    [Abstract] [Full Text] [Related]

  • 10. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
    Yamamoto N, Zou JP, Li XF, Takenaka H, Noda S, Fujii T, Ono S, Kobayashi Y, Mukaida N, Matsushima K.
    J Immunol; 1995 Mar 01; 154(5):2281-90. PubMed ID: 7868900
    [Abstract] [Full Text] [Related]

  • 11. Analysis of a cytostatic lymphokine produced by incubation of lymphocytes with tumor cells: relationship to leukoregulin and distinction from recombinant lymphotoxin, recombinant tumor necrosis factor, and natural killer cytotoxic factor.
    Sayers TJ, Ransom JH, Denn AC, Herberman RB, Ortaldo JR.
    J Immunol; 1986 Jul 01; 137(1):385-90. PubMed ID: 2423611
    [Abstract] [Full Text] [Related]

  • 12. Human interleukin 2 analogues that preferentially bind the intermediate-affinity interleukin 2 receptor lead to reduced secondary cytokine secretion: implications for the use of these interleukin 2 analogues in cancer immunotherapy.
    Heaton KM, Ju G, Grimm EA.
    Cancer Res; 1993 Jun 01; 53(11):2597-602. PubMed ID: 8495422
    [Abstract] [Full Text] [Related]

  • 13. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
    Elner SG, Elner VM, Bian ZM, Lukacs NW, Kurtz RM, Strieter RM, Kunkel SL.
    Invest Ophthalmol Vis Sci; 1997 Feb 01; 38(2):446-55. PubMed ID: 9040478
    [Abstract] [Full Text] [Related]

  • 14. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.
    Clin Cancer Res; 2000 Jun 01; 6(6):2268-78. PubMed ID: 10873077
    [Abstract] [Full Text] [Related]

  • 15. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.
    Albanesi C, Cavani A, Girolomoni G.
    J Immunol; 1999 Jan 01; 162(1):494-502. PubMed ID: 9886425
    [Abstract] [Full Text] [Related]

  • 16. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species.
    Pober JS, Lapierre LA, Stolpen AH, Brock TA, Springer TA, Fiers W, Bevilacqua MP, Mendrick DL, Gimbrone MA.
    J Immunol; 1987 May 15; 138(10):3319-24. PubMed ID: 3494766
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.
    Lin JY, Seguin R, Keller K, Chadee K.
    Immunology; 1995 Jul 15; 85(3):400-7. PubMed ID: 7558128
    [Abstract] [Full Text] [Related]

  • 18. A soluble factor produced by lamina propria mononuclear cells is required for TNF-alpha enhancement of IFN-gamma production by T cells.
    Prehn JL, Landers CJ, Targan SR.
    J Immunol; 1999 Oct 15; 163(8):4277-83. PubMed ID: 10510366
    [Abstract] [Full Text] [Related]

  • 19. Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses.
    Elner VM, Burnstine MA, Strieter RM, Kunkel SL, Elner SG.
    Exp Eye Res; 1997 Dec 15; 65(6):781-9. PubMed ID: 9441701
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-2 production by T cells: a study of the immunoregulatory actions of interferon-alpha, interferon-gamma, and tumor necrosis factor-alpha in phenotypically different T cell clones.
    Dao T, Holán V, Minowada J.
    Cell Immunol; 1993 Oct 15; 151(2):451-9. PubMed ID: 8402948
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.